sflorg.com
Estrogen Link to Crohn's Disease Discovered - Scientific Frontline
This study suggests a biological link between NOD2 gene dysfunction and estrogen signaling that could help explain why Crohn’s disease is more common in females and point to a new, hormone-related pathway to investigate for treatments.
Researchers studying IBD genetics, immune pathways, and sex differences; clinicians following basic science advances in Crohn’s disease; patients and caregivers interested in the biology behind sex disparities in IBD.
What To Know
Researchers at the University of Bath report a basic-science study (PLOS Biology) linking loss of NOD2 function to increased estrogen signaling that drives gut damage in a zebrafish model.
The team found that exposing healthy fish to estrogen reproduced the intestinal defects seen with NOD2 disruption, and that an estrogen receptor inhibitor reversed gut dysfunction in the NOD2-mutant fish. This is early, preclinical research using zebrafish to map cell-specific gene activity and hormone–immune interactions.
It suggests estrogen signaling may contribute to sex differences in Crohn’s disease and could be a potential therapeutic target worth further study. What this does not mean: these results are from animal experiments and do not establish that the same treatments or effects will occur in people.
Clinical research is needed before any change to care or use of hormone-targeted therapies can be recommended. Next steps: expect further lab work and, if supported, eventual clinical studies testing whether modulating estrogen signaling affects inflammation in people with NOD2-associated Crohn’s disease.
Findings come from a zebrafish model and were reported in PLOS Biology; animal-model results are hypothesis-generating and require replication in mammalian systems and clinical studies before affecting care.
